Amgen Pushes Forward in Diabetes with Array Deal
By Taskin Ahmed
Pharma Deals Review: Vol 2010 Issue 1 (Table of Contents)
Published: 14 Jan-2010
DOI: 10.3833/pdr.v2010.i1.1302 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Amgen has made further inroads into diabetes drug development by licensing a small-molecule glucokinase activator, ARRY-403, from Array BioPharma...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS